Cancer UrologyCancer UrologyОнкоурология1726-97761996-1812Publishing House ABV Press8110.17650/1726-9776-2012-8-1-49-55DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCERДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ МОЧЕПОЛОВОЙ СИСТЕМЫ. Рак мочевого пузыряDEVELOPMENT OF THE NOMOGRAM THAT PREDICTS PATHOLOGICAL LYMPH NODE INVOLVEMENT IN BLADDER CANCER PATIENTS BASED ON CLINICAL VARIABLESПОСТРОЕНИЕ НОМОГРАММЫ, ПРОГНОЗИРУЮЩЕЙ МЕТАСТАТИЧЕСКОЕ ПОРАЖЕНИЕ ЛИМФАТИЧЕСКИХ УЗЛОВ ПРИ РАКЕ МОЧЕВОГО ПУЗЫРЯ ПО КЛИНИЧЕСКИМ ДАННЫМMirylenkoL. V.МириленкоЛ. В.
Belarus
ludamirilen@gmail.comSukonkoO. G.СуконкоО. Г.
Belarus
ludamirilen@gmail.comPravorovA. V.ПраворовА. В.
Belarus
ludamirilen@gmail.comRolevichA. I.РолевичА. И.
Belarus
ludamirilen@gmail.comMavrichevA. S.МавричевА. С.
Belarus
ludamirilen@gmail.comN.N. Alexandrov National Cancer Centre of BelarusРНПЦ онкологии и медицинской радиологии им. Н.Н. Александрова, Минск300320128149552607201426072014https://oncourology.abvpress.ru/oncur/article/view/81

Objective: to develop nomogram based on clinical variables, that predicts pathological lymph node involvement (рN+) in bladder cancer patients.

Material and methods: We used data of 511 patients with bladder cancer, that have undergone radical cystectomy between 1999 and 2008 at N.N. Alexandrov National Cancer Centre. Mono- and multivariate logistic regression analyses were used for pN+ prediction on preoperative data. Coefficients from logistic regression equation were used to construct the nomogram. Nomogram accuracy was evaluated with concordance index and construction of the calibration plot. Internal validation by bootstrap method with 200 variants of dataset was performed.

Results: We developed nomogram, that includes: clinical stage сТ, tumor grade, tumor macroscopic appearance, and creatinine level. Bootstrap-corrected prognostic accuracy of nomogram was 71,6%, that was 9,4% better than clinical stage accuracy.

Conclusion: utilization of developed nomogram can significantly improve pathologic tumor stage prediction accuracy that may be used to select patients for neoadjuvant chemotherapy.

bladder cancerradical cystectomyN stagelymph nodespredictionnomogramрак мочевого пузырярадикальная цистэктомияметастазылимфатические узлыпрогнозномограмма1. Schoenberg M. Management of invasive and metastatic bladder cancer. In: Walsh P.C., Retik A.B., Stamey T.A., Vaughan E.D. Jr, editors. Campbell’s Urology, 8th edn. Philadelphia: WB Saunders Co, 2002; p 2803–17.Schoenberg M. Management of invasive and metastatic bladder cancer. In: Walsh P.C., Retik A.B., Stamey T.A., Vaughan E.D. Jr, editors. Campbell’s Urology, 8th edn. Philadelphia: WB Saunders Co, 2002; p 2803–17.2. Liedberg F., Mansson W. Lymph node metastasis in bladder cancer. Eur Urol 2006; 49(1):13−21.Liedberg F., Mansson W. Lymph node metastasis in bladder cancer. Eur Urol 2006; 49(1):13−21.3. Jager G.J., Barentsz J.O., Oosterhof G.O. et al. Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared- rapid gradient echo sequence. AJR Am J Roentgenol 1996; 167(6):1503−7.Jager G.J., Barentsz J.O., Oosterhof G.O. et al. Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared- rapid gradient echo sequence. AJR Am J Roentgenol 1996; 167(6):1503−7.4. Oyen R.H., Van Poppel H.P., A meye F.E. et al. Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy: prospective study of 285 patients. Radiology 1994; 190(2):315−22.Oyen R.H., Van Poppel H.P., A meye F.E. et al. Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy: prospective study of 285 patients. Radiology 1994; 190(2):315−22.5. Barentsz J.O., Engelbrecht M.R., Witjes J.A. et al. MR imaging of the male pelvis. Eur Radiol 1999;9(9):1722−36.Barentsz J.O., Engelbrecht M.R., Witjes J.A. et al. MR imaging of the male pelvis. Eur Radiol 1999;9(9):1722−36.6. Bradley E., Tibshirani R.J. Monographs on statistics and applied probability: an introduction to the bootstrap. Boca Raton: Champman and Hall/CRC, 1993.Bradley E., Tibshirani R.J. Monographs on statistics and applied probability: an introduction to the bootstrap. Boca Raton: Champman and Hall/CRC, 1993.7. Karakiewicz P., Shariat S., Palapattu G. et al. Precystectomy Nomogram for Prediction of Advanced Bladder Cancer Stage. Eur Urol 2006; 50(6): 1254–62.Karakiewicz P., Shariat S., Palapattu G. et al. Precystectomy Nomogram for Prediction of Advanced Bladder Cancer Stage. Eur Urol 2006; 50(6): 1254–62.8. Harrell F.E. Jr. Regression modeling strategies with applications to linear models, logistic regression, and survival analysis. New York, NY, Springer Verlag, 2001.Harrell F.E. Jr. Regression modeling strategies with applications to linear models, logistic regression, and survival analysis. New York, NY, Springer Verlag, 2001.9. Kattan M.W. Nomograms. Introduction. Semin Urol Oncol 2002;20:79–81.Kattan M.W. Nomograms. Introduction. Semin Urol Oncol 2002;20:79–81.10. Kattan M.W. Comparison of Cox regression with other methods for determining prediction models and nomograms. J Urol 2003;170(6):6–9.Kattan M.W. Comparison of Cox regression with other methods for determining prediction models and nomograms. J Urol 2003;170(6):6–9.11. Steyerberg E.W., Bleeker S.E., Moll H.A. et al. Internal and external validation of predictive models: a simulation study of bias and precision in small samples. J Clin Epidemiol 2003;56(5):441–7.Steyerberg E.W., Bleeker S.E., Moll H.A. et al. Internal and external validation of predictive models: a simulation study of bias and precision in small samples. J Clin Epidemiol 2003;56(5):441–7.12. Stenzl A., Cowan N.C., De Santis M. et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 2011 Jun; 59(6):1009−18.Stenzl A., Cowan N.C., De Santis M. et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 2011 Jun; 59(6):1009−18.13. Niegisch G., Albers P. Which patients benefit the most from neoadjuvant chemotherapy in advanced bladder cancer? Curr Opin Urol 2011;21(5):434−9.Niegisch G., Albers P. Which patients benefit the most from neoadjuvant chemotherapy in advanced bladder cancer? Curr Opin Urol 2011;21(5):434−9.14. Lawrentschuk N., Colombo R., Hakenberg O.W. et al. Prevention and management of complications following radical cystectomy for bladder cancer. Eur Urol 2010;57(6):983−1001.Lawrentschuk N., Colombo R., Hakenberg O.W. et al. Prevention and management of complications following radical cystectomy for bladder cancer. Eur Urol 2010;57(6):983−1001.15. Lerner S.P. The role and extent of pelvic lymphadenectomy in the management of patients with invasive urothelial carcinoma. Curr Treat Options Oncol 2009;10(3−4):267−74.Lerner S.P. The role and extent of pelvic lymphadenectomy in the management of patients with invasive urothelial carcinoma. Curr Treat Options Oncol 2009;10(3−4):267−74.16. Shariat S., Margulis V., Lotan Y. et al. Nomograms for Bladder Cancer. Eur Urol 2008; 54(1): 41–53.Shariat S., Margulis V., Lotan Y. et al. Nomograms for Bladder Cancer. Eur Urol 2008; 54(1): 41–53.